Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Influence of Cardiac Decentralization on Cardioprotection

  • John G. Kingma ,

    john.kingma@fmed.ulaval.ca

    Affiliation Département de médecine, Pavillon Ferdinand-Vandry, 1050, avenue de la Médecine, Université Laval, Québec (Québec), Canada

  • Denys Simard,

    Affiliation Research Center, Institut universitaire de cardiologie et de pneumologie de Québec, 2725, chemin Sainte-Foy, Québec, Qc, Canada

  • Pierre Voisine,

    Affiliation Département de chirurgie, Pavillon Ferdinand-Vandry, 1050, avenue de la Médecine, Université Laval, Québec (Québec), Canada

  • Jacques R. Rouleau

    Affiliation Département de médecine, Pavillon Ferdinand-Vandry, 1050, avenue de la Médecine, Université Laval, Québec (Québec), Canada

Abstract

The role of cardiac nerves on development of myocardial tissue injury after acute coronary occlusion remains controversial. We investigated whether acute cardiac decentralization (surgical) modulates coronary flow reserve and myocardial protection in preconditioned dogs subject to ischemia-reperfusion. Experiments were conducted on four groups of anesthetised, open-chest dogs (n = 32): 1- controls (CTR, intact cardiac nerves), 2- ischemic preconditioning (PC; 4 cycles of 5-min IR), 3- cardiac decentralization (CD) and 4- CD+PC; all dogs underwent 60-min coronary occlusion and 180-min reperfusion. Coronary blood flow and reactive hyperemic responses were assessed using a blood volume flow probe. Infarct size (tetrazolium staining) was related to anatomic area at risk and coronary collateral blood flow (microspheres) in the anatomic area at risk. Post-ischemic reactive hyperemia and repayment-to-debt ratio responses were significantly reduced for all experimental groups; however, arterial perfusion pressure was not affected. Infarct size was reduced in CD dogs (18.6±4.3; p = 0.001, data are mean±1SD) compared to 25.2±5.5% in CTR dogs and was less in PC dogs as expected (13.5±3.2 vs. 25.2±5.5%; p = 0.001); after acute CD, PC protection was conserved (11.6±3.4 vs. 18.6±4.3%; p = 0.02). In conclusion, our findings provide strong evidence that myocardial protection against ischemic injury can be preserved independent of extrinsic cardiac nerve inputs.

Introduction

Intrathoracic ganglia on the heart and their interconnections coordinate with central neurons in the spinal cord, brain stem and supraspinal central neuronal regions and modulate autonomic control of heart function. [1] As such, control of heart function involves a hierarchy of neurons located within: central command (top level), intrathoracic extracardiac ganglia (mid level) and intrinsic cardiac ganglia (bottom level). [2], [3] Alterations in neuronal input at any level could affect overall cardiac control; [4][6] however, despite altered connectivity neurons within the intrinsic cardiac nervous system can generate spontaneous activity and regulate regional cardiac function reflexively [7].

Within the left ventricle sympathetic and parasympathetic nerves are localized near cardiac myocytes to permit rapid crosstalk [8]– loss of this crosstalk could influence myocyte responses to ischemia. The role of cardiac nerves on development of ischemic injury remains controversial. Regional myocardial ischemia activates the autonomic nervous system; excessive stimulation produces electrical instability and increased incidence of atrial and ventricular arrhythmias. [9], [10] The latter also alters the myocardial oxygen supply demand relationship to produce greater post-ischemic myocardial injury. Development of post-ischemic tissue injury has been studied in isolated heart and in situ experimental preparations where extracardiac nerves have been sectioned. While many studies use the term ‘cardiac denervation’ to describe their experimental preparation after surgical ablation of extracardiac inputs use of ‘cardiac decentralization’ may be a more accurate descriptor of the animal model as mid and bottom levels of the neuronal hierarchy appear to be intact. In large animal studies, disruption of the extracardiac nervous system exerts either protective [11] or adverse effects [12], [13] on infarct size after ischemic injury. Huang et al reported increased myocardial stunning and patchy necrosis in cardiac denervated animals and suggested that the absence of cardiac nerves impaired recovery of cardiac function. [14] Delayed, but not first window, preconditioning in a cardiac denervated porcine model requires intact cardiac nerves. [15] These findings document a critical role for cardiac nerves in development of ischemic injury and eventual recovery thereof. The present study in an in situ canine preparation examined the effect of cardiac decentralization on post-ischemic coronary vascular reserve and development of acute ischemic injury. We hypothesized that a loss of central command inputs (i.e. sympathetic and parasympathetic control) to the local neuronal hierarchy would diminish coronary vascular reserve and worsen myocyte necrosis.

Methods

Adult mongrel dogs of either sex (20–25 Kg) were used for these studies. Dogs were treated in compliance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication 85-23, revised 1996); Laval University is compliant with these guidelines (A5012-01). The experimental protocol was approved by the Laval University Animal Ethics Committee.

Surgical Preparation

Dogs were pre-medicated with acepromazine maleate (Atravet, 0.5 mg/Kg IM); anesthesia was induced with sodium pentobarbital (30 mg/Kg IV) and maintained with hourly administrations of 5 mg/Kg IV. After endotracheal intubation, dogs were ventilated with oxygen-enriched room air; respiratory rate and tidal volume were adjusted to maintain blood gases within physiological values. Butorphenol (0.2 mg/Kg IM) was administered for analgesia. Normothermia (38±1°C) was maintained with a water-jacketed Micro-Temp heating blanket (Zimmer, Dover, OH); temperature was continuously monitored with a thermal probe in the trachea and saline was given IV (250 mL/h) to replace fluid loss.

In the supine position, vascular introducer sheaths (8 Fr, Terumo Medical Corp., USA) were placed in the left and right femoral arteries; a triple-lumen central venous catheter (7 Fr, Arrow-Howes™, Arrow Intl. Inc., Reading, PA) was placed in the right femoral vein for administration of drugs and fluids. In the left lateral position the heart was exposed by thoracotomy. Extracardiac nerves were carefully dissected and excised; the stellate ganglia, ansae subclaviae and vagus nerves were targeted bilaterally. [16], [17] Completeness of cardiac decentralization prior to coronary occlusion and at the end of the experiment was verified by direct electrical stimulation and confirmed by the absence of change in heart rate and LV dynamics [13].

The heart was suspended in a pericardial cradle. The left anterior descending artery (LAD) was dissected distal to the first diagonal branch to allow positioning of a vascular clamp (for determination of coronary reactive hyperemia (RH) responses and coronary occlusion (CO)) and a blood volume flow probe (Transonic Systems, Ithaca, NY). Polyethylene catheters (7 Fr) were inserted into the internal thoracic artery (withdrawal of reference blood samples for microsphere studies) and left atrium (injection of microspheres). A 5 Fr micro-tipped pressure transducer (MPC500; Millar Instruments Inc., Houston, TX) was placed in the LV cavity through the apex to measure LV pressure and its first derivative; a 7 Fr Pigtail catheter was advanced to the aortic root via the left femoral artery to measure arterial pressures. After all catheters were positioned dogs were given heparin sodium (25 IU/Kg, IV) and allowed to stabilize for 30-min prior to data collection.

Left atrial and ascending aorta catheters were connected to Statham P23Db strain gauge manometers; zero was set at mid-chest level. The Millar micromanometer transducer was cross-calibrated with systolic aortic and diastolic left atrial pressures. Coronary blood flow was measured using a volume flow meter (Transonic Systems, Ithaca, NY). All data were continuously recorded and stored on computer hard drive for later analysis using AxoScope acquisition software. These parameters include heart rate, LV and aortic systolic/diastolic pressures, phasic and mean coronary blood flow. Rate-pressure product (RPP) was used as an indicator of myocardial oxygen demand and has been reported to correlate with myocardial oxygen consumption [18].

Experimental Protocol

The experimental design is depicted schematically in Fig. 1. Dogs were randomly assigned to one of four groups; controls (CTR) and cardiac decentralized (CD) dogs underwent a 40-min wait period (equivalent to time of ischemic preconditioning (PC) protocol). For PC we used the classical model initially reported by Murry et al. [19] PC and CD+PC dogs were subjected to 4 cycles of 5-min LAD occlusion and 5-min reperfusion. All dogs underwent 60-min acute CO and 180-min reperfusion (REP180).

thumbnail
Figure 1. Schematic illustration of the experimental protocols.

All dogs underwent 60-min acute CO and REP180. In CTR and CD dogs a 40-min wait period was allowed to compensate for time required for PC (4 cycles of 5-min CO/5-min reperfusion). The time at which reactive hyperemia (RH), nerve ablation (NA) and electrical nerve stimulation (ENS; outlined in Methods) was done is shown.

https://doi.org/10.1371/journal.pone.0079190.g001

RH responses within the ischemic stress zone (i.e. LAD vascular bed) were obtained to assess the maximal vasodilator capacity of this vascular bed under stable conditions prior to PC and at the end of the ischemia-reperfusion protocol; a 20-sec acute, regional CO was used as this degree of ischemia produces maximal dilatation [20] rather than adenosine since the latter can act as a preconditioning mimetic [21].

All dogs were given lidocaine (5 mg/Kg, IV) at 55-min CO to suppress ventricular arrhythmias. Hearts that developed ventricular fibrillation or sustained ventricular tachycardia were cardioverted (1 J/Kg) using internal paddles.

Coronary Collateral Blood Flow Measurements

Transmural myocardial blood flow was measured at 30-min CO using neutron activated microspheres (±15 µm; BioPAL Inc., Worcester, MA, U.S.A.) as previously described [22].

Area at Risk and Infarct Size

At the end of each study, the LAD was re-ligated at the original site of occlusion; the area at risk (AAR) was outlined by perfusion of the coronary ostium with Monastral blue dye. Under deep pentobarbital anesthesia, cardiac arrest was induced by intra-atrial injection of saturated potassium chloride. A 1.5% solution of warmed (37°C) 2,3,5-triphenyltetrazolium chloride was infused into the ischemic region via a cannula in the LAD (distal to the snare occluder) over 30-min. The heart was rapidly excised, rinsed in saline and fixed in 10% buffered formaldehyde. The LV was cut from apex to base and the outline of each slice, the necrotic area (AN) and the AAR were traced onto acetates. The LV area, AAR and AN were determined using a digitizing tablet (Summagraphics II Plus) interfaced with a personal computer and analyzed with Sigma Scan software (SPSS Inc., CA, U.S.A.). Results are expressed as the AAR and the AN indexed to AAR (%). Tissue samples from the mid-region of the LV within the AAR and from the non-ischemic LV were further subdivided into endocardial and epicardial pieces for blood flow (i.e., coronary collateral flow) analyses; blood and tissue samples were dried for 48 h at 50°C and sent to a core processing facility (BioPAL Inc., Worcester, MA); [22] blood flow is expressed as mL/min/g.

Data and Statistical Analyses

Differences in cardiac hemodynamics and regional blood flow were determined by ANOVA and multiple comparisons were performed using the Student-Newman-Keuls multiple range test. A probability (p) level of ≤0.05 was considered statistically significant; normality and variance assumptions were fulfilled. The influence of ventricular tachycardia/fibrillation on survival after the combined ischemia-reperfusion insult was determined using the Fisher Exact test and Chi-square analysis; all statistical analyses were carried out using SAS software (SAS Institute Inc., Cary, NC, U.S.A.). Sample size determination for these studies was based on the provision of a 90% power to detect, at a p≤0.05 significance level, a minimum 20 percent reduction/augmentation (expected standard deviation of ±8%) in infarct size.

RH responses were measured from strip chart recordings, baseline (Qbase) and peak (Qpeak) flow, flow debt and repayment volumes were determined as previously described; [20], [23] data are expressed as repayment-to-debt ratio. Coronary vascular conductance (CVC) at baseline and at peak flow during RH responses was calculated as the quotient of diastolic coronary blood flow and aortic pressure.

Development of tissue necrosis in the anesthetized canine is dependent on cardiac hemodynamics, AAR [18] and density of native collaterals; [24] all of these variables were considered in the statistical analyses. Coronary collateral blood flow within the ischemic zone (microspheres) was assessed at 30-min CO and infarct size was normalized to coronary collateral blood flow. Treatment effects of variables measured once (i.e., AN, AAR) were analyzed by ANOVA. [18] An analysis of covariance (ANCOVA) was also done to assess differences between experimental groups when variability due to coronary collateral flow (independent variable) was considered. The regression between infarct size and coronary collateral blood flow within the AAR was determined by a linear least-squares fit method. All analyses were conducted using the statistical package SAS, version 9.2 (SAS Institute Inc, Cary, NC).

Results

Thirty-two dogs (n = 8 per group) were randomly allocated to the study groups and all completed the experimental protocol. Incidence of ventricular tachycardia/fibrillation during ischemia/reperfusion (0/8 CTR; 2/8 PC; 1/8 CD; 1/8 CD+PC) was not statistically different. Arterial blood gas and hematocrit values (data not shown) were all within physiological levels.

Cardiac hemodynamic data are summarized in Table 1. Heart rate (HR), LV systolic pressure (LVPS) and mean arterial pressure (MAP) were all lower in CD dogs. LV dP/dt+ and dP/dt− which is used to assess LV contractility was significantly lower in CD dogs; CO produced a significant drop in dP/dt+ in all dogs. During reperfusion LV dP/dt+ values were consistently lower.

Changes in coronary RH responses (used to assess coronary flow reserve) produced by ischemia-reperfusion injury are reported in Table 2. After REP180, Qbase was significantly reduced in all groups and Qpeak decreased almost 50 percent less for each group; as such, 60-min CO resulted in an overall loss of coronary flow reserve (cf. Qpeak/Qbase) regardless of cardiac nerve status. While no change in CVCbase was detected at REP180, CVCpeak was significantly less in all experimental groups. Coronary blood flow repayment-to-debt ratio decreased markedly following ischemia-reperfusion in CTR and CD dogs even though arterial perfusion pressures remained stable (cf. Figure 2); no change was observed with PC pretreatment.

thumbnail
Figure 2. Repayment-to-debt ratios of coronary blood flow during RH in CTR (open circles), PC closed circles), CD (open squares) and CD+PC (closed squares) before CO (i.e. baseline) and at REP180.

Data are means±1SD; **p≤0.05 vs. before ischemia.

https://doi.org/10.1371/journal.pone.0079190.g002

thumbnail
Table 2. Summary of coronary reactive hyperemia responses.

https://doi.org/10.1371/journal.pone.0079190.t002

The AAR (% LV area) was similar for all experimental groups (CTR, 32±11; PC, 33±6; CD, 28±8; CD+PC, 27±7) as shown in Figure 3. As expected, infarct size (%AAR) was significantly decreased in PC (13.5±3.2%, mean±1SD, p = 0.001) compared to CTR (25.2±5.5%) dogs. Cardiac decentralization resulted in smaller infarcts compared to CTR dogs (18.6±4.3 vs. 25.2±5.5%; p = 0.001); infarct size was further reduced by PC in CD dogs (11.6±3.4%). The level of ischemia for each dog was similar as indicated by the level of coronary collateral blood flow within the AAR measured by microspheres at 30-min coronary occlusion (CTR, 0.06±0.02; PC, 0.07±0.03; CD, 0.07±0.02; CD+PC, 0.06±0.02 mL/min/g). Blood flow within non-ischemic myocardium at the same time point was: CTR, 1.51±0.34; PC, 1.13±0.19; CD, 1.25±0.21; CD+PC, 1.20±0.09 mL/min/g; p = NS).

thumbnail
Figure 3. Area at risk (% LV area; left panel) and myocardial infarct size (% AAR; right panel) are shown for all study groups.

Data are means±SEM; differences between groups were established by ANOVA with the Student’s-Newman-Keuls multiple range test.

https://doi.org/10.1371/journal.pone.0079190.g003

Although direct comparisons of infarct size by ANOVA demonstrate reduced tissue injury by PC (or CD) this statistical method does not take into consideration the important influence of coronary collateral blood flow (independent covariant) within the AAR on development of tissue necrosis. In CTR dogs an inverse relationship between coronary collateral blood flow and infarct size was obtained (i.e., low regional blood flow results in larger infarcts). [19] The infarct size/coronary collateral blood flow relation was shifted downward for PC, CD and CD+PC groups as shown in Figure 4; slopes of the regressions were similar for all experimental groups. These results suggest significant cardioprotection independent of coronary collateral flow levels in PC, CD and CD+PC dogs.

thumbnail
Figure 4. Infarct size (% AR) versus coronary collateral blood flow (mL/min/g).

Left panel: CTR (closed symbols; y = 32.4−112.6X, r2 = 0.203) versus PC (open symbols; y = 11.6−32.9X, r2 = 0.055) dogs. Middle panel: CTR (closed symbols; y = 32.4−112.6X, r2 = 0.203) versus CD (open symbols; y = 24.9−96.4X, r2 = 0.327). Right panel: CD (closed symbols; y = 24.9−96.4X, r2 = 0.327) versus CD+PC (open symbols; y = 15.5−60.7X, r2 = 0.079) dogs. The downward shift of the regression indicates significant protection that occurs independently of changes in coronary collateral blood flow. Each point represents an individual dog.

https://doi.org/10.1371/journal.pone.0079190.g004

Discussion

Results of the present study show that a 60-min period of ischemia substantially reduces coronary vascular reserve; a similar impairment of this parameter was observed after acute ablation of all extracardiac neuronal inputs (i.e. cardiac decentralization). These effects were independent of pretreatment by cardiac conditioning. Myocardial necrosis was significantly reduced in CD dogs; a similar level of tissue protection was afforded by conditioning pretreatment independent of CD.

Coronary flow reserve can evaluate coronary microvessel function and provides well-established risk and prognostic variables. [25] Reduced cardiac contractile function post-ischemia further affects the relation between adequate oxygen supply and ventricular remodeling. [26] In the present study coronary flow within the ischemic stress zone after ischemia and reperfusion was significantly diminished in all experimental groups; peak flow values were also markedly lower and resulted in a marked lowering of coronary flow reserve. Interestingly, neither ischemic preconditioning nor cardiac decentralization attenuated the effect of ischemia on coronary flow reserve. These data are not consistent with earlier studies showing preserved coronary function by cardiac conditioning. [27][30] We expected to see improved coronary vessel function in PC and CD animals due to either upregulation of intracellular cytoprotective pathways or reduced metabolic demands, respectively. Furthermore, these data cannot explain the observed reduction in infarct size in either PC or CD animals; a close relation has been reported between infarct size and distribution of myocardial blood flow within the anatomic risk area [31].

In CD animals not subject to PC pretreatment infarct size was significantly smaller. While these findings are in agreement with those previously reported [11], [32] important differences exist with respect to the cardiac denervation and coronary occlusion protocols used. Furthermore, our findings contrast with those reported by Lavallee et al in dogs subject to total coronary occlusion. [13] Many different conditioning strategies either in situ in animals with intact cardiac nerves or in isolated buffer-perfused hearts have been reported in the literature to reduce myocardial injury and infarct size. [33] We report here that preconditioning mediated protection against ischemia-reperfusion injury was not abrogated by cardiac decentralization. Kudej et al also documented significant infarct size reduction by PC pretreatment after acute cardiac denervation (using surgical and chemical methods). [15] While they maintain that intact cardiac nerves are not essential for first window preconditioning we contend that the role functional neurons within the cardiac ganglia play in post-ischemic myocardial adaptation needs to be better defined. Indeed, sub-populations of neurons have even been shown to influence reflex cardiac functions even after their physical disconnection from central command [34], [35] due to maintained synaptic communication between intrinsic cardiac neurons [4].

Sympathetic dysinnervation secondary to myocardial infarction has been reported in animal and human studies. [36], [37] However, the injury threshold of cardiac neurons (sympathetic and parasympathetic) during ischemia-reperfusion remains unclear; sympathetic impairment might also exceed the area of decreased perfusion and myocyte necrosis. [38], [39] Ischemic stress stimulates release of autocoids (i.e. adenosine, bradykinin), nitric oxide and reactive oxygen species that trigger cellular signal transduction pathways; most of these compounds initiate responses in somata and axons of the mammalian intrinsic cardiac nervous system. [40] It is conceivable that intrinsic cardiac neurons and ischemic preconditioning share common pathways to stimulate survival of myocytes against ischemia; the intrinsic cardiac nervous system might even play an important role in mediating the benefits of preconditioning.

There are some limitations in our study. We used an open-chest, isoflurane-anesthetized canine experimental preparation. A priori consideration was not given to either surgical or anesthetic preconditioning since all animals were treated similarly. Additional risk factors that influence myocardial infarct size such as duration and depth (i.e., residual flow deficit in the ischemic zone) of ischemia and anatomic risk zone size were measured in the present studies and were uniform for all study groups. [41], [42] In this paper we use the term ‘decentralized’ rather than ‘denervated’ to describe the experimental model; earlier studies used surgical or chemical ablation methods, or a combination of both to create the so-called cardiac denervation model. Surgical ablation of intrapericardial (ventrolateral cardiac nerve and stripping tissue from pulmonary veins, pulmonary artery and superior vena cava) nerve inputs to the intrinsic cardiac nervous system does not specifically target intrinsic cardiac ganglionated plexuses and associated pericardial nerves. Since these ganglia are functional use of the term cardiac denervation may be erroneous. As such, while acute bilateral ablation of extracardiac nerves, as done in the present study, enabled disconnection from central command (i.e. top level) peripheral nerve networks still regulate cardiac function. Future studies could be directed towards evaluation of the role of specific intrinsic cardiac nervous system ganglionated plexuses on conditioning-mediated cardioprotection.

In conclusion, cardioprotection against ischemic injury is conserved by preconditioning even when the target tissues are disconnected from central command. These findings suggest that preconditioning and the intrinsic cardiac nervous system could share common pathways to delay development of myocyte necrosis. Results of the present studies could have implications for understanding physiopathology of ischemia-induced heart failure. Further studies are needed to determine whether neuromodulation of the intrinsic cardiac nervous system would be beneficial against ischemia-reperfusion.

Acknowledgments

The authors acknowledge the assistance of the animal care staff at the Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec.

Author Contributions

Conceived and designed the experiments: JGK DS. Performed the experiments: JGK DS JRR. Analyzed the data: JGK DS PV JRR. Contributed reagents/materials/analysis tools: JGK PV JRR. Wrote the paper: JGK DS PV JRR.

References

  1. 1. Arora RC, Ardell JL, Armour JA (2000) Cardiac Denervation and Cardiac Function. Curr Interv Cardiol Rep 2: 188–195.
  2. 2. Cardinal R, Page P, Vermeulen M, Ardell JL, Armour JA (2009) Spatially divergent cardiac responses to nicotinic stimulation of ganglionated plexus neurons in the canine heart. Auton Neurosci 145: 55–62 S1566-0702(08)00242-7 [pii];10.1016/j.autneu.2008.11.007 [doi].
  3. 3. Kember G, Armour JA, Zamir M (2013) Neural control hierarchy of the heart has not evolved to deal with myocardial ischemia. Physiol Genomics 45: 638–644 physiolgenomics.00027.2013 [pii];10.1152/physiolgenomics.00027.2013 [doi].
  4. 4. Smith FM, McGuirt AS, Hoover DB, Armour JA, Ardell JL (2001) Chronic decentralization of the heart differentially remodels canine intrinsic cardiac neuron muscarinic receptors. Am J Physiol Heart Circ Physiol 281: H1919–H1930.
  5. 5. Huang MH, Smith FM, Armour JA (1994) Modulation of in situ canine intrinsic cardiac neuronal activity by nicotine, muscarininc and b-adrenergic agonists. Am J Physiol (Regulatory, Integrative, Comparative Physiology 33) 265: R659–R669.
  6. 6. Huang MH, Wolf SG, Armour JA (1994) Ventricular arrhythmias induced by chemically modified intrinsic cardiac neurones. Cardiovasc Res 28: 636–642. 0008-6363(94)90166-X [pii].
  7. 7. Murphy DA, Thompson GW, Ardell JL, McCraty R, Stevenson RS, et al. (2000) The heart reinnervates after transplantation. Ann Thorac Surg 69: 1769–1781.
  8. 8. Canty JM Jr, Fallavollita JA (2003) Sympathetic nerves and myocyte necrosis: more than meets the eye. Circ Res 93: 796–798 10.1161/01.RES.0000100845.27406.FB [doi];93/9/796 [pii].
  9. 9. Armour JA (1991) Anatomy and function of the intrathoracic neurons regulating the mammalian heart. In: Zucker IH, Gilmore JP, editors. Reflex Control of the Circulation. Boca Raton, Ann Arbor, Boston: CRC Press. 1–37.
  10. 10. Armour JA, Collier K, Kember G, Ardell JL (1998) Differential selectivity of cardiac neurons in separate intrathoracic autonomic ganglia. Am J Physiol 274: R939–R949.
  11. 11. Jones CE, Devous MD Sr, Thomas JX Jr, Dupont E (1978) The effect of chronic cardiac denervation on infarct size following acute coronary occlusion. Am Heart J 95: 738–746.
  12. 12. Huang CH, Vatner SF, Peppas AP, Yang G, Kudej RK (2003) Cardiac nerves affect myocardial stunning through reactive oxygen and nitric oxide mechanisms. Circ Res 93: 866–873 10.1161/01.RES.0000097762.64561.D2 [doi];01.RES.0000097762.64561.D2 [pii].
  13. 13. Lavallee M, Amano J, Vatner SF, Manders WT, Randall WC, et al. (1985) Adverse effects of chronic cardiac denervation in conscious dogs with myocardial ischemia. Circ Res 57: 383–392.
  14. 14. Huang M-H, Ardell JL, Hanna BD, Wolf SG, Armour JA (1993) Effects of transient coronary artery occlusion on canine intrinsic cardiac neuronal activity. Integrative Physiological and Behavioral Science 28: 5–21.
  15. 15. Kudej RK, Shen YT, Peppas AP, Huang CH, Chen W, et al. (2006) Obligatory role of cardiac nerves and alpha1-adrenergic receptors for the second window of ischemic preconditioning in conscious pigs. Circ Res 99: 1270–1276.
  16. 16. Kingma JG, Simard D, Voisine P, Rouleau JR (2011) Role of the autonomic nervous system in cardioprotection by remote preconditioning in isoflurane-anaesthetized dogs. Cardiovasc Res 89: 384–391 cvq306 [pii];10.1093/cvr/cvq306 [doi].
  17. 17. Rouleau JR, Simard D, Rodrigue N, Blouin A, Kingma JG Jr (2002) Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition. Auton Neurosci 97: 12–18.
  18. 18. Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield JC, et al. (1985) Animal models for protecting ischemic myocardium (AMPIM): results of the NHLBI cooperative study. Comparison of the unconscious and conscious dog models. Circ Res 56: 651–665.
  19. 19. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124–1136.
  20. 20. Olsson RA (1975) Myocardial reactive hyperemia. Circ Res 37(3): 263.
  21. 21. Mentzer RM Jr, Birjiniuk V, Khuri S, Lowe JE, Rahko PS, et al. (1999) Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg 229: 643–649.
  22. 22. Kingma JG Jr, Simard D, Rouleau JR (2005) Comparison of neutron activated and radiolabeled microsphere methods for measurement of transmural myocardial blood flow in dogs. J Thromb Thrombolysis 19: 201–208.
  23. 23. Shen YT, Wiedmann RT, Lynch JJ Jr, Gould RJ (2000) Platelet glycoprotein IIb/IIIa receptor inhibitor preserves coronary flow reserve during progressive coronary arteriostenosis in swine. Arterioscler Thromb Vasc Biol 20: 2309–2315.
  24. 24. Jugdutt BI, Hutchins GM, Bulkley BH, Becker LC (1979) Myocardial infarction in the conscious dog: three-dimensional mapping of infarct, collateral flow and region at risk. Circulation 60: 1141–1150.
  25. 25. Tio RA, Dabeshlim A, Siebelink HM, de Sutter J, Hillege HL, et al. (2009) Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 50: 214–219 jnumed.108.054395 [pii];10.2967/jnumed.108.054395 [doi].
  26. 26. Juarez-Orozco LE, Glauche J, Alexanderson E, Zeebregts CJ, Boersma HH, et al.. (2013) Myocardial perfusion reserve in spared myocardium: correlation with infarct size and left ventricular ejection fraction. Eur J Nucl Med Mol Imaging. 10.1007/s00259-013-2394-y [doi].
  27. 27. Laude K, Beauchamp P, Thuillez C, Richard V (2002) Endothelial protective effects of preconditioning. Cardiovasc Res 55: 466–473.
  28. 28. Reffelmann T, Kloner RA (2002) Is Microvascular Protection by Cariporide And Ischemic Preconditioning Causally Linked to Myocardial Salvage? Am J Physiol Heart Circ Physiol.
  29. 29. Kaeffer N, Richard V, Francois A, Lallemand F, Henry JP, et al. (1996) Preconditioning prevents chronic reperfusion-induced coronary endothelial dysfunction in rats. Am J Physiol 271: H842–H849.
  30. 30. Richard V, Kaeffer N, Tron C, Thuillez C (1994) Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation 89: 1254–1261.
  31. 31. Reffelmann T, Kloner RA (2002) Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 283: H1099–H1107.
  32. 32. Jones CE, Beck LY, Dupont E, Barnes GE (1978) Effects of coronary ligation of the chronically sympathectomized dog ventricle. Am J Physiol 235: H429–H434.
  33. 33. Hausenloy DJ, Yellon DM (2009) Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 204: 334–341 S0021-9150(08)00748-X [pii];10.1016/j.atherosclerosis.2008.10.029 [doi].
  34. 34. Ardell JL, Cardinal R, Vermeulen M, Armour JA (2009) Dorsal spinal cord stimulation obtunds the capacity of intrathoracic extracardiac neurons to transduce myocardial ischemia. Am J Physiol Regul Integr Comp Physiol 297: R470–R477.
  35. 35. Armour JA (1986) Neuronal activity recorded extracellularly in chronically decentralized in situ canine middle cervical ganglia. Can J Physiol Pharmacol 64: 1038–1046.
  36. 36. Fallavollita JA, Canty JM Jr (2010) Dysinnervated but viable myocardium in ischemic heart disease. J Nucl Cardiol 17: 1107–1115 10.1007/s12350-010-9292-5 [doi].
  37. 37. Bulow HP, Stahl F, Lauer B, Nekolla SG, Schuler G, et al. (2003) Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction. Nucl Med Commun 24: 233–239 10.1097/01.mnm.0000061044.24401.6d [doi].
  38. 38. Barber MJ, Mueller TM, Henry DP, Felten SY, Zipes DP (1983) Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 67: 787–796.
  39. 39. Dae MW, Herre JM, O’Connell JW, Botvinick EH, Newman D, et al. (1991) Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 17: 1416–1423.
  40. 40. Armour JA (2008) Potential clinical relevance of the ‘little brain’ on the mammalian heart. Exp Physiol 93: 165–176.
  41. 41. Reimer KA, Jennings RB (1979) The changing anatomic reference base of evolving myocardial infarction. Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage, and acute inflammation. Circulation 60: 866–875.
  42. 42. Miura T, Downey JM, Ooiwa H, Ogawa S, Adachi T, et al. (1989) Progression of myocardial infarction in a collateral flow deficient species. Jpn Heart J 30: 695–708.